NCT03984448 2026-05-13Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell LymphomasNational Cancer Institute (NCI)Phase 2/3 Active not recruiting363 enrolled